Sex Differences Distinguish Intracortical Glutamate Receptor-Mediated Regulation of Extracellular Dopamine Levels in the Prefrontal Cortex of Adult Rats

Cerebral Cortex

Volumn 26, Issue 2, 2016, Pages 599-610

  Locklear, M N ^a,b   Cohen, A B ^b   Jone, A ^a,b   Kritzer, M F ^b  

^a Graduate Program in Neuroscience   (United States)

^b Stony Brook University   (United States)

Author keywords

Hyperdopaminergia; Hypodopaminergia; NMDA R hypofunction; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; DOPAMINE; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTRANSMITTER; 2,3-DIOXO-6-NITRO-7-SULFAMOYLBENZO(F)QUINOXALINE; 2-AMINO-5-PHOSPHOPENTANOIC ACID; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; AMINO ACID RECEPTOR AFFECTING AGENT; BENZYLAMINE DERIVATIVE; BICUCULLINE; GABAERGIC RECEPTOR AFFECTING AGENT; PHOSPHINIC ACID DERIVATIVE; QUINOXALINE DERIVATIVE; SODIUM CHANNEL BLOCKING AGENT; TETRODOTOXIN; VALINE; [3 (3,4 DICHLOROBENZYLAMINO)PROPYL](DIETHOXYMETHYL)PHOSPHINIC ACID;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; EXECUTIVE FUNCTION; FEMALE; HOMEOSTASIS; IN VIVO STUDY; MALE; MICRODIALYSIS; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SEX DIFFERENCE; ANALOGS AND DERIVATIVES; ANALYSIS OF VARIANCE; ANIMAL; DIALYSIS; DRUG EFFECTS; ESTRUS CYCLE; EXTRACELLULAR FLUID; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; SEX DIFFERENTIATION; SPRAGUE DAWLEY RAT; TIME FACTOR;

ANALYSIS OF VARIANCE; ANIMALS; BENZYLAMINES; BICUCULLINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIALYSIS; DOPAMINE; ESTROUS CYCLE; EXCITATORY AMINO ACID AGENTS; EXTRACELLULAR FLUID; FEMALE; GABA AGENTS; GABA-A RECEPTOR ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; MALE; PHOSPHINIC ACIDS; PREFRONTAL CORTEX; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUTAMATE; SEX DIFFERENTIATION; SODIUM CHANNEL BLOCKERS; TETRODOTOXIN; TIME FACTORS; VALINE;

EID: 84960422309     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhu222     Document Type: Article

References (121)

1. Arnsten AF. 2009. Toward a new understanDing of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction. CNS Drugs. 23(Suppl 1):33-41.
2. Arnsten AF, Li BM. 2005. Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry. 57:1377-1384.
3. Aubele T, Kritzer MF. 2012. Androgen influence on prefrontal dopamine systems in adult male rats: localization of cognate intracellular receptors in medial prefrontal projections to the ventral tegmental area and effects of gonadectomy and hormone replacement on glutamate-stimulated extracellular dopamine level. Cereb Cortex. 22:1799-1812.
4. Aultman JM, Moghaddam B. 2001. Distinct contributions of glutamate and dopamine receptors to temporal aspects of rodent working memory using a clinically relevant task. Psychopharmacology (Berl). 153:353-364.
5. Balla A, Nattini ME, Sershen H, Lajtha A, Dunlop DS, Javitt DC. 2009. GABAB/NMDA receptor interaction in the regulation of extracellular dopamine levels in rodent prefrontal cortex and striatum. Neuropharmacology. 56:915-921.
6. Berridge KC, Robinson TE. 1998. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev. 28:309-369.
7. Bujas M, Pericic D, Jazvinscak M. 1997. Influence of gender and gonadectomy on bicuculline-induced convulsions and on GABAA receptors. Brain Res Bull. 43:411-416.
8. Canuso CM, Pandina G. 2007. Gender and schizophrenia. Psychopharmacol Bull. 40:178-190.
9. Carr DB, Sesack SR. 2000. GABA-containing neurons in the rat ventral tegmental area project to the prefrontal cortex. Synapse. 38:114-123.
10. Cervenka S, Hedman E, Ikoma Y, Djurfeldt DR, Ruck C, Halldin C, Lindefors N. 2012. Changes in dopamine D2-receptor binDing are associated to symptom reduction after psychotherapy in social anxiety disorder. Transl Psychiatry. 2:e120.
11. Cools R, D'Esposito M. 2011. Inverted-U-shaped dopamine actions on human working memory and cognitive control. Biol Psychiatry. 69: e113-e125.
12. Cryan JF, Kaupmann K. 2005. Don't worry 'B' happy! A role for GABA (B) receptors in anxiety and depression. Trends Pharmacol Sci. 26:36-43.
13. Dalla C, Antoniou K, Kokras N, Drossopoulou G, Papathanasiou G, Bekris S, Daskas S, Papadopoulou-Daifoti Z. 2008. Sex differences in the effects of two stress paradigms on dopaminergic neurotransmission. Physiol Behav. 93:595-605.
14. Dalley JW, Cardinal RN, Robbins TW. 2004. Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev. 28:771-784.
15. Davis KL, Kahn RS, Ko G, Davidson M. 1991. Dopamine in schizophrenia-a review and reconceptualization. Am J Psychiatry. 148:1474-1486.
16. Del Arco A, Mora F. 1999. Effects of endogenous glutamate on extracellular concentrations of GABA, dopamine, and dopamine metabolites in the prefrontal cortex of the freely moving rat: involvement of NMDA and AMPA/KA receptors. Neurochem Res. 24:1027-1035.
17. Del Arco A, Mora F. 2000. Endogenous dopamine potentiates the effects of glutamate on extracellular GABA in the prefrontal cortex of the freely moving rat. Brain Res Bull. 53:339-345.
18. Del Arco A, Mora F. 2002. NMDA and AMPA/kainate glutamatergic agonists increase the extracellular concentrations of GABA in the prefrontal cortex of the freely moving rat: modulation by endogenous dopamine. Brain Res Bull. 57:623-630.
19. Del Arco A, Ronzoni G, Mora F. 2011. Prefrontal stimulation of GABAA receptors counteracts the corticolimbic hyperactivity produced by NMDA antagonists in the prefrontal cortex of the rat. Psychopharmacology (Berl). 214:525-536.
20. de Olmos S, Bueno A, Bender C, Lorenzo A, de Olmos J. 2008. Sex differences and influence of gonadal hormones on MK801-induced neuronal degeneration in the granular retrosplenial cortex of the rat. Brain Struct Funct. 213:229-238.
21. Deutch AY. 1992. The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia. J Neural Transm Suppl. 36:61-89.
22. Deutch AY, Lee MC, Gillham MH, Cameron DA, Goldstein M, Iadarola MJ. 1991. Stress selectively increases fos protein in dopamine neurons innervating the prefrontal cortex. Cereb Cortex. 1:273-292.
23. Dubois B, Pillon B. 1997. Cognitive deficits in Parkinson's disease. J Neurol. 244:2-8.
24. Duchesne A, Dufresne MM, Sullivan RM. 2009. Sex differences in corticolimbic dopamine and serotonin systems in the rat and the effect of postnatal handling. Prog Neuropsychopharmacol Biol Psychiatry. 33:251-261.
25. Dumontheil I, Roggeman C, Ziermans T, Peyrard-Janvid M, Matsson H, Kere J, Klingberg T. 2011. Influence of the COMT genotype on working memory and brain activity changes during development. Biol Psychiatry. 70:222-229.
26. Durstewitz D, Seamans JK. 2002. The computational role of dopamine D1 receptors in working memory. Neural Netw. 15:561-572.
27. Durstewitz D, Seamans JK, Sejnowski TJ. 2000. Neurocomputational models of working memory. Nat Neurosci. 3(Suppl):1184-1191.
28. Eisenberg DP, Berman KF. 2010. Executive function, neural circuitry, and genetic mechanisms in schizophrenia. Neuropsychopharmacology. 35:258-277.
29. Fallon S, Shearman E, Sershen H, Lajtha A. 2007. The effects of glutamate and GABA receptor antagonists on nicotine-induced neurotransmitter changes in cognitive areas. Neurochem Res. 32:535-553.
30. Faraji J, Metz GA, Sutherland RJ. 2010. Characterization of spatial performance in male and female Long-Evans rats by means of the Morris water task and the ziggurat task. Brain Res Bull. 81:164-172.
31. Feenstra MG, Botterblom MH, van Uum JF. 2002. Behavioral arousal and increased dopamine efflux after blockade of NMDA-receptors in the prefrontal cortex are dependent on activation of glutamatergic neurotransmission. Neuropharmacology. 42:752-763.
32. Feenstra MG, van der Weij W, Botterblom MH. 1995. Concentrationdependent dual action of locally applied N-methyl-D-aspartate on extracellular dopamine in the rat prefrontal cortex in vivo. Neurosci Lett. 201:175-178.
33. Feinstein I, Kritzer MF. 2013. Acute N-methyl-D-aspartate receptor hypofunction induced by MK801 evokes sex-specific changes in behaviors observed in open-field testing in adult male and proestrus female rats. Neuroscience. 228:200-214.
34. Fejgin K, Palsson E, Wass C, Finnerty N, Lowry J, Klamer D. 2009. Prefrontal GABA(B) receptor activation attenuates phencyclidineinduced impairments of prepulse inhibition: involvement of nitric oxide. Neuropsychopharmacology. 34:1673-1684.
35. Frye CA. 2010. Effects and mechanisms of progestogens and androgens in ictal activity. Epilepsia. 51(Suppl 3):135-140.
36. Frye CA. 2008. Hormonal influences on seizures: basic neurobiology. Int Rev Neurobiol. 83:27-77.
37. Goldberg TE, Egan MF, Gscheidle T, Coppola R, Weickert T, Kolachana BS, Goldman D, Weinberger DR. 2003. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch Gen Psychiatry. 60:889-896.
38. Goldman JM, Murr AS, Cooper RL. 2007. The rodent estrous cycle: characterization of vaginal cytology and its utility in toxicological studies. Birth Defects Res B Dev Reprod Toxicol. 80:84-97.
39. Goldman PS, Crawford HT, Stokes LP, Galkin TW, Rosvold HE. 1974. Sex-dependent behavioral effects of cerebral cortical lesions in the developing rhesus monkey. Science. 186:540-542.
40. Goldman-Rakic PS, Funahashi S, Bruce CJ. 1990. Neocortical memory circuits. Cold Spring Harb Symp Quant Biol. 55:1025-1038.
41. Goldstein JM, Cohen LS, Horton NJ, Lee H, Andersen S, Tohen M, Crawford A, Tollefson G. 2002. Sex differences in clinical response to olanzapine compared with haloperidol. Psychiatry Res. 110:27-37.
42. Gonzalez-Burgos G, Lewis DA. 2012. NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia. Schizophr Bull. 38:950-957.
43. Gould E, Woolley CS, Frankfurt M, McEwen BS. 1990. Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci. 10:1286-1291.
44. Grobin AC, Deutch AY. 1998. Dopaminergic regulation of extracellular gamma-aminobutyric acid levels in the prefrontal cortex of the rat. J Pharmacol Exp Ther. 285:350-357.
45. Gruber AJ, Calhoon GG, Shusterman I, Schoenbaum G, Roesch MR, O'Donnell P. 2010. More is less: a disinhibited prefrontal cortex impairs cognitive flexibility. J Neurosci. 30:17102-17110.
46. Hajszan T, MacLusky NJ, Leranth C. 2008. Role of androgens and the androgen receptor in remodeling of spine synapses in limbic brain areas. Horm Behav. 53:638-646.
47. Harte M, O'Connor WT. 2005. Evidence for a selective prefrontal cortical GABA(B) receptor-mediated inhibition of glutamate release in the ventral tegmental area: a dual probe microdialysis study in the awake rat. Neuroscience. 130:215-222.
48. Homayoun H, Moghaddam B. 2007. NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci. 27:11496-11500.
49. Jackson ME, Homayoun H, Moghaddam B. 2004. NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex. Proc Natl Acad Sci USA. 101:8467-8472.
50. Javitt DC. 2007. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. Int Rev Neurobiol. 78:69-108.
51. Javitt DC. 2010. Glutamatergic theories of schizophrenia. Isr J Psychiatry Relat Sci. 47:4-16.
52. Jedema HP, Moghddam B. 1996. Characterization of excitatory amino acid modulation of dopamine release in the prefrontal cortex of conscious rats. J Neurochem. 66:1448-1453.
53. Jin S. 1997. AMPA-and kainate-receptors differentially mediate excitatory amino acid-induced dopamine and acetylcholine release from rat striatal slices. Neuropharmacology. 36:1503-1510.
54. Kajta M, Budziszewska B, MarszalM, LasonW. 2001. Effects of 17-beta estradiol and estriol on NMDA-induced toxicity and apoptosis in primary cultures of rat cortical neurons. J Physiol Pharmacol. 52:437-446.
55. Kantrowitz JT, Javitt DC. 2010. N-methyl-D-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? Brain Res Bull. 83:108-121.
56. Kehrer C, Maziashvili N, Dugladze T, Gloveli T. 2008. Altered excitatory-inhibitory balance in the NMDA-hypofunction model of schizophrenia. Front Mol Neurosci. 1:6.
57. Kostakis E, Smith C, Jang MK, Martin SC, Richards KG, Russek SJ, Gibbs TT, Farb DH. 2013. The neuroactive steroid pregnenolone sulfate stimulates trafficking of functional N-methyl D-aspartate receptors to the cell surface via a noncanonical, G protein, and Ca2+-dependent mechanism. Mol Pharmacol. 84:261-274.
58. Kritzer MF, Creutz LM. 2008. Region and sex differences in constituent dopamine neurons and immunoreactivity for intracellular estrogen and androgen receptors in mesocortical projections in rats. J Neurosci. 28:9525-9535.
59. Lacreuse A, Herndon JG, Killiany RJ, Rosene DL, Moss MB. 1999. Spatial cognition in rhesus monkeys: male superiority declines with age. Horm Behav. 36:70-76.
60. Lai DC, Tseng YC, Hou YM, Guo HR. 2012. Gender and geographic differences in the prevalence of autism spectrum disorders in children: analysis of data from the national disability registry of Taiwan. Res Dev Disabil. 33:909-915.
61. Landau SM, Lal R, O'Neil JP, Baker S, Jagust WJ. 2009. Striatal dopamine and working memory. Cereb Cortex. 19:445-454.
62. Laruelle M, Frankle WG, Narendran R, Kegeles LS, Abi-Dargham A. 2005. Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation. Clin Ther. 27(Suppl A):S16-S24.
63. Leranth C, Hajszan T, MacLusky NJ. 2004. Androgens increase spine synapse density in the CA1 hippocampal subfield of ovariectomized female rats. J Neurosci. 24:495-499.
64. Leranth C, Petnehazy O, MacLusky NJ. 2003. Gonadal hormones affect spine synaptic density in the CA1 hippocampal subfield of male rats. J Neurosci. 23:1588-1592.
65. Leung A, Chue P. 2000. Sex differences in schizophrenia: a review of the literature. Acta Psychiatr Scand Suppl. 401:3-38.
66. Lewis DA, Curley AA, Glausier JR, Volk DW. 2012. Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci. 35:57-67.
67. Lewis DA, Moghaddam B. 2006. Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Arch Neurol. 63:1372-1376.
68. Lewis DA, Pierri JN, Volk DW, Melchitzky DS, Woo TU. 1999. Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia. Biol Psychiatry. 46:616-626.
69. Lu WY, Jackson MF, Bai D, Orser BA, MacDonald JF. 2000. In CA1 pyramidal neurons of the hippocampus protein kinase C regulates calcium-dependent inactivation of NMDA receptors. J Neurosci. 20:4452-4461.
70. Marcondes FK, Bianchi FJ, Tanno AP. 2002. Determination of the estrous cycle phases of rats: some helpful considerations. Braz J Biol. 62:609-614.
71. Margolis EB, Lock H, Chefer VI, Shippenberg TS, Hjelmstad GO, Fields HL. 2006. Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex. Proc Natl Acad Sci USA. 103:2938-2942.
72. Masana M, Santana N, Artigas F, Bortolozzi A. 2012. Dopamine neurotransmission and atypical antipsychotics in prefrontal cortex: a critical review. Curr Top Med Chem. 12:2357-2374.
73. Mendrek A, Stip E. 2011. Sexual dimorphism in schizophrenia: is there a need for gender-based protocols? Expert Rev Neurother. 11:951-959.
74. Miller IN, Cronin-Golomb A. 2010. Gender differences in Parkinson's disease: clinical characteristics and cognition. Mov Disord. 25:2695-2703.
75. Moghaddam B, Javitt D. 2012. From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology. 37:4-15.
76. Murphy BL, Arnsten AF, Goldman-Rakic PS, Roth RH. 1996. Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc Natl Acad Sci USA. 93:1325-1329.
77. Narayanan NS, Rodnitzky RL, Uc EY. 2013. Prefrontal dopamine signaling and cognitive symptoms of Parkinson's disease. Rev Neurosci. 24:267-278.
78. Nguyen TV, Yao M, Pike CJ. 2009. Dihydrotestosterone activates CREB signaling in cultured hippocampal neurons. Brain Res. 1298:1-12.
79. Niwa M, Kamiya A, Murai R, Kubo K, Gruber AJ, Tomita K, Lu L, Tomisato S, Jaaro-Peled H, Seshadri S et al. 2010. Knockdown of DISC1 by in utero gene transfer disturbs postnatal dopaminergic maturation in the frontal cortex and leads to adult behavioral deficits. Neuron. 65:480-489.
80. O'Donnell P. 2010. Adolescent maturation of cortical dopamine. Neurotox Res. 18:306-312.
81. O'Donnell P. 2003. Dopamine gating of forebrain neural ensembles. Eur J Neurosci. 17:429-435.
82. Ortiz-Gil J, Pomarol-Clotet E, Salvador R, Canales-Rodriguez EJ, Sarro S, Gomar JJ, Guerrero A, Sans-Sansa B, Capdevila A, Junque C et al. 2011. Neural correlates of cognitive impairment in schizophrenia. Br J Psychiatry. 199:202-210.
83. Ott BR, Tate CA, Gordon NM, Heindel WC. 1996. Gender differences in the behavioral manifestations of Alzheimer's disease. J Am Geriatr Soc. 44:583-587.
84. Overman WH, Bachevalier J, Schuhmann E, Ryan P. 1996. Cognitive gender differences in very young children parallel biologically based cognitive gender differences in monkeys. Behav Neurosci. 110:673-684.
85. Paxinos G, Watson C. 1998. The rat brain in stereotaxic coordinates. San Diego: Academic Press.
86. Pericic D, Manev H, Bujas M. 1996. Gonadal hormones and picrotoxininduced convulsions in male and female rats. Brain Res. 736:174-179.
87. Petry NM, Kirby KN, Kranzler HR. 2002. Effects of gender and family history of alcohol dependence on a behavioral task of impulsivity in healthy subjects. J Stud Alcohol. 63:83-90.
88. Povysheva NV, Johnson JW. 2012. Tonic NMDA receptor-mediated current in prefrontal cortical pyramidal cells and fast-spiking interneurons. J Neurophysiol. 107:2232-2243.
89. Pozzo-Miller LD, Inoue T, Murphy DD. 1999. Estradiol increases spine density and NMDA-dependent Ca2+ transients in spines of CA1 pyramidal neurons from hippocampal slices. J Neurophysiol. 81:1404-1411.
90. Retaux S, Besson MJ, Penit-Soria J. 1991. Opposing effects of dopamine D2 receptor stimulation on the spontaneous and the electrically evoked release of [3H]GABA on rat prefrontal cortex slices. Neuroscience. 42:61-71.
91. Roof RL, Zhang Q, Glasier MM, Stein DG. 1993. Gender-specific impairment on Morris water maze task after entorhinal cortex lesion. Behav Brain Res. 57:47-51.
92. Santiago M, Machado A, Cano J. 1993. Regulation of the prefrontal cortical dopamine release by GABAA and GABAB receptor agonists and antagonists. Brain Res. 630:28-31.
93. Scott L, Aperia A. 2009. Interaction between N-methyl-D-aspartic acid receptors and D1 dopamine receptors: an important mechanism for brain plasticity. Neuroscience. 158:62-66.
94. Seamans JK, Gorelova N, Durstewitz D, Yang CR. 2001. Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons. J Neurosci. 21:3628-3638.
95. Seamans JK, Yang CR. 2004. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol. 74:1-58.
96. Seeman P. 2009. Glutamate and dopamine components in schizophrenia. J Psychiatry Neurosci. 34:143-149.
97. Smith CC, McMahon LL. 2006. Estradiol-induced increase in the magnitude of long-term potentiation is prevented by blocking NR2Bcontaining receptors. J Neurosci. 26:8517-8522.
98. Smith CC, Vedder LC, Nelson AR, Bredemann TM, McMahon LL. 2010. Duration of estrogen deprivation, not chronological age, prevents estrogen's ability to enhance hippocampal synaptic physiology. Proc Natl Acad Sci USA. 107:19543-19548.
99. Stan A, Lewis DA. 2012. Altered cortical GABA neurotransmission in schizophrenia: insights into novel therapeutic strategies. Curr Pharm Biotechnol. 13:1557-1562.
100. Swanson LW. 1982. The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res Bull. 9:321-353.
101. Szymanski S, Lieberman J, Pollack S, Kane JM, Safferman A, Munne R, Umbricht D, Woerner M, Masiar S, Kronig M. 1996. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics. Biol Psychiatry. 39:249-254.
102. Taherianfard M, Sharifi M, Tadjali M, Kohkiloezadeh M. 2012. Modulation of NR1 subunit of N-methyl-D-aspartate receptor by ovariectomy and passive avoidance learning. Iran J Neurol. 11:140-145.
103. Takahata R, Moghaddam B. 1998. Glutamatergic regulation of basal and stimulus-activated dopamine release in the prefrontal cortex. J Neurochem. 71:1443-1449.
104. Tandon PN. 2013. Not so silent: the human prefrontal cortex. Neurol India. 61:578-580.
105. Tanila H, Taira T, Piepponen TP, Honkanen A. 1994. Effect of sex and age on brain monoamines and spatial learning in rats. Neurobiol Aging. 15:733-741.
106. Tong ZY, Overton PG, Clark D. 1996. Antagonism of NMDA receptors but not AMPA/kainate receptors blocks bursting in dopaminergic neurons induced by electrical stimulation of the prefrontal cortex. J Neural Transm. 103:889-904.
107. Tseng KY, O'Donnell P. 2004. Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms. J Neurosci. 24:5131-5139.
108. Tseng KY, O'Donnell P. 2007. D2 dopamine receptors recruit a GABA component for their attenuation of excitatory synaptic transmission in the adult rat prefrontal cortex. Synapse. 61:843-850.
109. Usall J, Suarez D, Haro JM. 2007. Gender differences in response to antipsychotic treatment in outpatients with schizophrenia. Psychiatry Res. 153:225-231.
110. Vedder LC, Smith CC, Flannigan AE, McMahon LL. 2013. Estradiol-induced increase in novel object recognition requires hippocampal NR2Bcontaining NMDA receptors. Hippocampus. 23:108-115.
111. Verma A, Moghaddam B. 1996. NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. J Neurosci. 16:373-379.
112. Wang Y, Neubauer FB, Luscher HR, Thurley K. 2010. GABAB receptordependent modulation of network activity in the rat prefrontal cortex in vitro. Eur J Neurosci. 31:1582-1594.
113. Williams GV, Castner SA. 2006. Under the curve: critical issues for elucidating D1 receptor function in working memory. Neuroscience. 139:263-276.
114. Woolley CS, McEwen BS. 1993. Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J Comp Neurol. 336:293-306.
115. Woolley DG, Vermaercke B, Op de Beeck H, Wagemans J, Gantois I, D'Hooge R, Swinnen SP, Wenderoth N. 2010. Sex differences in human virtual water maze performance: novel measures reveal the relative contribution of directional responDing and spatial knowledge. Behav Brain Res. 208:408-414.
116. Wu WR, Li N, Sorg BA. 2002. Regulation of medial prefrontal cortex dopamine by alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptors. Neuroscience. 114:507-516.
117. Xu TX, Sotnikova TD, Liang C, Zhang J, Jung JU, Spealman RD, GainetDinov RR, Yao WD. 2009. Hyperdopaminergic tone erodes prefrontal long-term potential via a D2 receptor-operated protein phosphatase gate. J Neurosci. 29:14086-14099.
118. Yonezawa Y, Kuroki T, Kawahara T, Tashiro N, Uchimura H. 1998. Involvement of gamma-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex. Eur J Pharmacol. 341:45-56.
119. Zahrt J, Taylor JR, Mathew RG, Arnsten AF. 1997. Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci. 17:8528-8535.
120. Zgaljardic DJ, Borod JC, FolDi NS, Mattis P. 2003. A review of the cognitive and behavioral sequelae of Parkinson's disease: relationship to frontostriatal circuitry. Cogn Behav Neurol. 16:193-210.
121. Zheng P, Zhang XX, Bunney BS, Shi WX. 1999. Opposite modulation of cortical N-methyl-D-aspartate receptor-mediated responses by low and high concentrations of dopamine. Neuroscience. 91:527-535.